Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Insights from the HELIOS-B Trial
Posted inCardiology Clinical Updates news

Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Insights from the HELIOS-B Trial

This review synthesizes evidence on the prevalence and prognostic value of right ventricular dysfunction in ATTR-CM and the therapeutic impact of vutrisiran on RV function from the HELIOS-B trial, underscoring RV free wall strain as a key biomarker and treatment target.
Enhanced Outcomes with Combined Intrahepatic and Periduodenal Lymphatic Embolization in Congenital Heart Disease-associated Protein-Losing Enteropathy
Posted inCardiology Gastroenterology news

Enhanced Outcomes with Combined Intrahepatic and Periduodenal Lymphatic Embolization in Congenital Heart Disease-associated Protein-Losing Enteropathy

Combined intrahepatic and periduodenal lymphatic embolization significantly improves protein balance and remission duration in congenital heart disease patients with protein-losing enteropathy compared to intrahepatic embolization alone, offering a promising targeted interventional strategy.
Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry
Posted inCardiology Neurology news

Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry

This prospective registry reveals a significantly increased risk of stroke or transient ischemic attack within 30 days after pulsed field ablation compared to radiofrequency ablation for atrial fibrillation, highlighting important safety considerations and the need for careful surveillance.
Impact of Third-Trimester Energy Restriction on Postnatal Maternal and Infant Body Composition After Gestational Diabetes: Insights from the DiGest Follow-up Study
Posted inDiabetes & Endocrinology news OB/GYN & Women’s Health

Impact of Third-Trimester Energy Restriction on Postnatal Maternal and Infant Body Composition After Gestational Diabetes: Insights from the DiGest Follow-up Study

Third-trimester energy restriction in women with gestational diabetes and elevated BMI does not adversely affect infant growth or body composition through the first postnatal year, suggesting safety of modest maternal weight loss in late pregnancy.